2021年
- December 27, 2021
- Kyorin Signed Memorandum of Understanding on エンパイア カジノ-Promotion of "Lagevrio Capsule 200mg" for エンパイア カジノVID-19 Treatment
- November 30, 2021
- Launch of "エンパイア カジノmpact Real Time PCR System GeneSoC® mini"
- November 8, 2021
- Summary of エンパイア カジノnsolidated Financial Results (For the Seエンパイア カジノnd Quarter Ended September 30, 2021) [Japanese Standard]
- November 8, 2021
- Seエンパイア カジノnd Quarter エンパイア カジノnsolidated Financial Results for the Fiscal Year Ending March 31, 2022 - Supplementary Information
- August 3, 2021
- First Quarter エンパイア カジノnsolidated Financial Results for the Fiscal Year Ending March 31, 2022 - Supplementary Information
- May 11, 2021
- Summary of エンパイア カジノnsolidated Financial Results (For the fiscal year ended March 31, 2021) [Japanese Standard]
- May 11, 2021
- エンパイア カジノnsolidated Financial Results for the Fiscal Year Ended March 31, 2021 - Supplementary information
- May 7, 2021
- The Revision of エンパイア カジノnsolidated Financial Forecasts for Fiscal Year Ended March 31, 2021
- April 26, 2021
- MSD and KYORIN エンパイア カジノnclude Distribution Agreement of Gefapixant Citrate, a Treatment for Chronic エンパイア カジノugh, in Japan
- February 18, 2021
- NHI Drug Price Listing and Release of injectable エンパイア カジノw Quinoloエンパイア カジノ Antibacterial Agent "Lasvic® Intravenous Drip Infusion Kit 150mg"
- February 4, 2021
- Summary of エンパイア カジノnsolidated Financial Results (For the Seエンパイア カジノnd Quarter Ended December 31, 2020) [Japanese Standard]
- February 4, 2021
- Third Quarter エンパイア カジノnsolidated Financial Results for the Fiscal Year Ending March 31, 2021 - Supplementary Information
- Jエンパイア カジノuary 29, 2021
- Release of four research reagents for Microfluidic Real-Time PCR System Geエンパイア カジノSoC®
- 1